The Korean Journal of Medicine

  • 제80권5호
  • /
  • Pages.491-498
  • /
  • 2011
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

과민성장증후군의 병태생리와 진단

Pathophysiology and Diagnosis of Irritable Bowel Syndrome

  • 강혜원 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 정혜경 (이화여자대학교 의학전문대학원 내과학교실)
  • Kang, Hye-Won (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Jung, Hye-Kyung (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • 발행 : 2011.05.01
⟨ 이전 논문 다음 논문 ⟩

초록

Irritable bowel syndrome (IBS) is a very common functional gastrointestinal disorder characterized by abdominal pain ordiscomfort with bowel habit changes. However, its pathogenesis and pathyphysiology have been poorly understood. Therewere many robust functional and anatomical evidences in Korea for visceral hypersensitivity, low-grade inflammation andimmunologic alterations, brain-gut interaction and genetic factors in the development of IBS. The link between pathophysiologicchanges and gastrointestinal symptoms would be the strong basis for the relevance of target therapy in this condition. The ROME IIIcriteria represent the current gold standard for the identification of characteristic and supportive symptoms of IBS and for thecategorization of IBS patients into symptom-based subgroups with exclusion of organic diseases. There were some limitations inuse of Rome III criteria in the clinical practice and research fields. Test of Rome III are needed, especially in Korea.

키워드

참고문헌

  1. 박정호, 변정식, 신운건 등. 과민성장증후군의 진단: 체계적인 문헌고찰. 대한소화기학회지 2010;55:308-315.
  2. Liu J, Hou X. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China. J Gastroenterol Hepatol 2011;26:881-893.
  3. Shin F, Motoyori K. Gene, environment, and brain-gut interaction in irritable bowel syndrome. J Gastroenterol Hepatol 2011;26: 110-115.
  4. Moon W, Lee OY, Kim JM, et al. Rectal accommodation in irritable bowel syndrome. Korean J Neurogastroenterol Motil 2007;13:132-137.
  5. Yu BH, Kang EH, Kim HS, et al. Beta adrenergic receptor sensitivity, mood state and colonic sensation in patients with irritable bowel syndrome. Korean J Neurogastroenterol Motil 2006;12:63-68.
  6. Jun DW, Lee OY, Yang SY, et al. Differences of sigmoid accommodation according to the subtype of irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:129-134.
  7. Yang JH, Lee JS, Hong SJ, et al. The rectal perception in patients with constipation predominant irritable bowel syndrome and functional constipation. Korean J Neurogastroenterol Motil 2005; 11:58-65.
  8. Lee OY, Yoon BC, Choi HS. Sigmoid discomfort thresholds in irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:38-43.
  9. Kang EH, Phee PL, Lee JH, et al. Beta adrenergic receptor function and anxiety in patients with irritable bowel syndrome. J Korean Neuropsyhiatr Assoc 2004;43:40-45.
  10. Kim HS, Phee PL, Lee JH, et al. The role of rectal hypersensitivity in the diagnosis of irritable bowel syndrome. Korean J Neurogastroenterol Motil 2003;9:119-124.
  11. Lee KJ, Kim JH, Hahm KB, et al. The factors related to rectal hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Korean J Gastroenterol 2001;37:173-178.
  12. Mayer EA, Tillisch K, Bradesi S, et al. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006;24:919-933. https://doi.org/10.1111/j.1365-2036.2006.03078.x
  13. Merts H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distension. Gastroenterology 2000;118:842-848. https://doi.org/10.1016/S0016-5085(00)70170-3
  14. Yuan YZ, Tao RJ, Xu B, et al. Functional brain imaging in irritable bowel syndrome with rectal balloon distention by using fMRI. World J Gastroenterol 2003;5:1356-1360.
  15. Mach T. The brain-gut axis in irritable bowel syndrome-clinical aspects. Med Sci Monit 2004;10:125-131.
  16. Uday CG, Prabhat R. Post-infectious irritable bowel syndrome: The past, the present and the future, Gastroenterology 2011; 26:94-101.
  17. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006;101: 1894-1899. https://doi.org/10.1111/j.1572-0241.2006.00654.x
  18. Park HS, Han DS, Hyun YS, et al. Postinfectious irritable bowel syndrome after clostridium difficile infection. Intest Res 2009; 7:100-104.
  19. La JH, Kim TW, Sung TS, et al. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J Vet Sci 2004;5:314-324.
  20. Lee JS, Jung SA, Kim SE, et al. The frequency of post infectious irritable bowel syndrome (PI-IBS) in patients with acute diarrhea and a comparison with colonoscopic findings. Korean J Neurogastroenterol Motil 2004;10:43-48.
  21. Park CH, Joo YE, Choi SK, et al. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J Korean Med Sci 2003;18:204-210.
  22. Kim HS, Lim HJ, Park H, et al. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute shigella infection: an observation in a small case control study. Yonsei Med J 2010;51:45-51. https://doi.org/10.3349/ymj.2010.51.1.45
  23. Anne S, Willem MV, Airi P. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010;156:3205-3215. https://doi.org/10.1099/mic.0.043257-0
  24. Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am 2010;24:961-975. https://doi.org/10.1016/j.idc.2010.07.005
  25. Whorwell PJ, McVallum M, Creed FH, et al. Non-colonic features of irritable bowel syndrome. Gut 1986;27:37-40. https://doi.org/10.1136/gut.27.1.37
  26. Kalantar JS, Locke GR, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52:1703-1707. https://doi.org/10.1136/gut.52.12.1703
  27. Morris YA, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-1317. https://doi.org/10.1111/j.1572-0241.1998.440_j.x
  28. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804. https://doi.org/10.1053/gast.2001.27995
  29. Yuri AS, Gloria M, Petersen G, et al. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:1057-1065. https://doi.org/10.1016/S1542-3565(05)00184-9
  30. Park SY, Rew JS, Lee SM, et al. Association of CCK2 receptor gene polymorphisms and irritable bowel syndrome in Korean. J Neurogastroenterol Moril 2010;16:71-76. https://doi.org/10.5056/jnm.2010.16.1.71
  31. Lee HJ, Lee SY, Choi JE, et al. G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome. Neurogastroenterol Motil 2010;22:758-763. https://doi.org/10.1111/j.1365-2982.2010.01496.x
  32. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:2812-2819. https://doi.org/10.1111/j.1572-0241.2002.07027.x
  33. Han SH, Lee OY, Bae SC, et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 2006;21:1687-1692. https://doi.org/10.1111/j.1440-1746.2006.04269.x
  34. Park DW, Lee OY, Shim SG, et al. The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III. J Neurogastroenterol Motil 2010;16:186-193. https://doi.org/10.5056/jnm.2010.16.2.186
  35. Jeong JB, Yang YM, Jeon WJ, et al. Postprandial colonic motor activity in patients with irritable bowel syndrome. Korean J Gastrointest Motil 2000;6:20-30.
  36. Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:120-130. https://doi.org/10.5056/jnm.2010.16.2.120
  37. Park SY, Park MH, Yoon KW, et al. Plasma 5-Hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome. Gut Liver 2009;3:26-30. https://doi.org/10.5009/gnl.2009.3.1.26
  38. Park HY, Jang JH, Lee YJ, et al. Serotonin transporter gene and G-protein beta 3 C825T gene polymorphism in patient with functional dyspepsia and irritable bowel syndrome. Korean J Neurogastroenterol Motil 2009;15:58-64.
  39. Kim HS, Park HJ, Lim JH, et al. The role of pro-and antiinflammatory cytokine gene polymorphisms in the development of post-infectious irritable bowel syndrome. Korean J Neurogastroenterol Motil 2006;12:41-47.
  40. Park H, Lee DY, Kim MS, et al. Serotonin transporter gene polymorphism and its relationship to plasma serotonin in irritable bowel syndrome. Korean J Neurogastroenterol Motil 2004;10: 125-129.
  41. Lee DY, Park H, Kim WH, et al. Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome. Korean J Gastroenterol 2004;43:18-22.
  42. Park JH, Park DI, Kim JH, et al. The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome. Gut Liver 2009;3:174-179. https://doi.org/10.5009/gnl.2009.3.3.174
  43. Hong KS, Kang HW, Im JP, et al. Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome. Gut Liver 2009;3:101-107. https://doi.org/10.5009/gnl.2009.3.2.101
  44. Eum J, Rhee KH, Cho YK, et al. Therapeutic effects of $Agio^{(R)}$ 18g per day in patients with constipation dominant irritable bowel syndrome and chronic constipation. Korean J Neurogastroenterol Motil 2008;14:115-121.
  45. Paik CN, Choi MG, Nam KW, et al. The prevalence of small intestinal bacterial overgrowth in Korean patients with irritable bowel syndrome. Korean J Neurogastroenterol Motil 2007;13: 38-44.
  46. Kim YG, Moon JT, Lee KM, et al. The effect of probiotcs on symptoms of irritable bowel syndrome. Korean J Gastroenterol 2006;47:413-419.
  47. Kim HS, Kim MS, Ji SW, et al. The development of irritable bowel syndrome after Shigella infection: 3 year follow up study. Korean J Gastroenterol 2006;47:300-305.
  48. Choi JH, Nah BK, Leem JM, et al. Mucosal mast cells in irritable bowel syndrome. Korean J Neurogastroenterol Motil 2004;10: 57-62.